Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Krebs Biochemicals & IndustriesBOM:524518 -0.44%40 Days Inventory is 5,334.54 as of Mar. 2026, which is 3999% above its 10-year median of 130.13. GuruFocus rates BOM:524518 with a GF Score™ of 40/100 and a GF Value™ of ₹37.85 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 920 Drug Manufacturers companies, Krebs Biochemicals & Industries ranks worse than 99.78% on this metric.
The historical rank and industry rank for Krebs Biochemicals & Industries's Days Inventory or its related term are showing as below:
BOM:524518'
s Days Inventory Range Over the Past 10 Years
Min: 97.08 Med: 130.13 Max: 5482.99
Current: 5437.46
During the past 13 years, Krebs Biochemicals & Industries's highest Days Inventory was 5482.99. The lowest was 97.08. And the median was 130.13.
BOM:524518's Days Inventory is ranked worse than 99.78% of 920
companies
in the Drug Manufacturers industry
Industry Median: 165.19
vs BOM:524518: 5437.46
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Krebs Biochemicals & Industries's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.02.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Krebs Biochemicals & Industries's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.84.
Krebs Biochemicals & Industries (BOM:524518) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Krebs Biochemicals & Industries's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Krebs Biochemicals & Industries's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Krebs Biochemicals & Industries Days Inventory Related Terms
Krebs Biochemicals & Industries Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Krebs Biochemicals & Industries Days Inventory Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Krebs Biochemicals & Industries's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Krebs Biochemicals & Industries Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Krebs Biochemicals & Industries's Days Inventory distribution charts can be found below:
* The bar in red indicates where Krebs Biochemicals & Industries's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Krebs Biochemicals & Industries (BOM:524518) has a Days Inventory of 5,334.54 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Krebs Biochemicals & Industries and its competitors. This is 3999% above median its historical median of 130.13. Over the past decade, Krebs Biochemicals & Industries' Days Inventory has ranged from 97.08 to 5,482.99. According to the industry distribution chart, Krebs Biochemicals & Industries ranks #918 out of 920 companies in the Drug Manufacturers industry, placing it in the top 99.8%.
Is Krebs Biochemicals & Industries' Days Inventory too high?
Krebs Biochemicals & Industries' current Days Inventory of 5,334.54 is 3999% above median its 10-year median of 130.13. Over the past 10 years, this metric has ranged from a low of 97.08 to a high of 5,482.99. The Drug Manufacturers industry median Days Inventory is 165.19. Krebs Biochemicals & Industries' value of 5,334.54 is 3129.3% above this industry median. Based on the distribution chart, Krebs Biochemicals & Industries ranks #918 out of 920 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Krebs Biochemicals & Industries has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Krebs Biochemicals & Industries' Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Krebs Biochemicals & Industries ranks #918 out of 920 companies for Days Inventory. This places Krebs Biochemicals & Industries in the lower half of its industry. The industry median Days Inventory is 165.19. Krebs Biochemicals & Industries' value of 5,334.54 is 3129.3% above this benchmark. Historically, Krebs Biochemicals & Industries' own Days Inventory has ranged from 97.08 to 5,482.99 over the past decade. While the company's 10-year median is 130.13 vs. the industry median of 165.19, Krebs Biochemicals & Industries has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.19, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Krebs Biochemicals & Industries's current Days Inventory of 5,334.54 is 3129.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Krebs Biochemicals & Industries and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Krebs Biochemicals & Industries's current Days Inventory is 5,334.54, which is 3999% above median its own 10-year median of 130.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krebs Biochemicals & Industries stock overvalued right now?
Based on GuruFocus' analysis, Krebs Biochemicals & Industries (BOM:524518) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹37.85, compared to a current price of ₹57.00 — trading 50.6% above its estimated fair value. The current Days Inventory is 5,334.54, which is 3999% above median its 10-year median of 130.13 and 3129.3% above the Drug Manufacturers industry median of 165.19. Krebs Biochemicals & Industries' overall GF Score™ is 40/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Krebs Biochemicals & Industries (BOM:524518), the current Days Inventory is 5,334.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Krebs Biochemicals & Industries (BOM:524518) Overvalued in 2026?
Based on GuruFocus' analysis, Krebs Biochemicals & Industries stock appears to be overvalued.
The current stock price of ₹57.00 is trading 50.6% above its estimated GF Value™ of ₹37.85.
GuruFocus considers Krebs Biochemicals & Industries to be Significantly Overvalued.
Key valuation signals for BOM:524518:
Days Inventory: 5,334.54 (3999% above median its 10-year median of 130.13)
GF Value™: ₹37.85 vs. price of ₹57.00 (50.6% above fair value)
Industry Position: 3129.3% above the Drug Manufacturers median (#918 of 920)
No single metric tells the full story. See the BOM:524518 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Krebs Biochemicals & Industries Ltd is a biochemical company in India. It is engaged in the business of manufacture of active pharmaceutical ingredients. It has two manufacturing plants in Andhra Pradesh, India - one in Nellore and one in Vizag both Units are equipped for chemical synthesis, fermentation, and enzymatic technologies providing Krebs with production capacity.
40GF Score
Get the complete analysis for BOM:524518
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524518 has been successfully added to your 
